This inventor holds 14 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 8 EPO patents. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, The United States of America as Represented by the Department of Health, Hoffmann-La Roche Inc.. Active years: 1998-2016.
Location History:
- Bethesda, MD (US) (2014)
- Potomac, MD (US) (1998 - 2016)
Company Filing History:
11 out of 3,690 
3 out of 1,217 
1 out of 5,020 
Years Active: 1998-2016
Title: Inventions and Innovations of Byungkook Lee
Introduction
Byungkook Lee is a prominent inventor based in Potomac, MD, with a remarkable portfolio of 14 patents. His work primarily focuses on innovations in the field of biotechnology, specifically targeting cancer treatment and immunogenicity of exotoxins.
Latest Patents
Among his latest inventions are groundbreaking developments in the design and application of engineered exotoxins. One notable patent presents an exotoxin A (PE) that comprises an amino acid sequence with modifications affecting B-cell and T-cell epitopes. This invention goes further by detailing related chimeric molecules, nucleic acids, recombinant expression vectors, host cells, and pharmaceutical compositions. Additionally, it outlines methods for treating or preventing cancer in mammals, inhibiting target cell growth, and producing both the exotoxin and the chimeric molecule.
Another significant patent focuses on mutated exotoxins that possess reduced immunogenicity compared to their native counterparts. These PEs feature specific mutations that minimize antibody binding to several PE epitopes. This patent also includes nucleic acids that encode these mutated PEs, associated chimeric molecules and their compositions, along with methods for effective utilization in therapies.
Career Highlights
Byungkook Lee has contributed significantly to the field through his association with esteemed institutions. He has worked with the United States of America as represented by the Secretary of the Department of Health and Human Services, as well as the United States of America as represented by the Department of Health. His innovations have potential implications for advancing cancer treatment methodologies.
Collaborations
Throughout his career, Lee has collaborated with distinguished experts in his field, notably Ira H. Pastan and Ulrich Brinkmann. These partnerships have likely fostered an environment conducive to innovation and excellence in biotechnology.
Conclusion
Byungkook Lee's contributions to the landscape of biotechnology through his inventions hold significant promise for cancer therapeutics and the modification of exotoxins. His ongoing work and collaborations underscore the importance of innovation in improving healthcare solutions. With 14 patents to his name, Lee continues to push the boundaries of scientific research and application.